REMICADE®

Remicade® is a TNF-alpha (tumor necrosis factor-alpha) inhibitor containing Infliximab, a chimeric monoclonal antibody designed to treat inflammatory autoimmune conditions. Manufactured by MSD, this medication works by blocking TNF-alpha, a key driver of inflammation, helping reduce symptoms and prevent long-term joint or tissue damage.

Supplied as a 100 mg vial for intravenous infusion, Remicade® is widely used in both clinical and hospital settings to manage severe cases of rheumatoid arthritis, Crohn’s disease, ankylosing spondylitis, and ulcerative colitis. With proven efficacy and a well-established safety profile, it is an essential treatment for improving quality of life in patients with chronic inflammatory diseases.

Remicade is also used to treat ulcerative colitis and Crohn’s disease in adults and children at least 6 years old.

Main Treatment Areas

Remicade® (Infliximab) is indicated for the treatment of several autoimmune and inflammatory diseases, including:

1. Rheumatoid Arthritis: Reduces joint inflammation and prevents long-term joint damage when used with methotrexate.
2. Crohn’s Disease: Manages symptoms of moderate-to-severe active Crohn’s disease and fistulizing Crohn’s disease.
3. Ulcerative Colitis: Effective for reducing inflammation and improving symptoms of active ulcerative colitis.
4. Psoriatic Arthritis: Relieves joint pain and swelling while managing psoriasis skin symptoms.
5. Ankylosing Spondylitis: Treats spinal inflammation and stiffness, improving mobility and reducing discomfort.
6. Plaque Psoriasis: Targets severe chronic plaque psoriasis, alleviating skin inflammation and lesions.

Key Benefits of Remicade®

• Targeted Action: Directly inhibits TNF-alpha, a major contributor to chronic inflammation in autoimmune diseases.
• Proven Efficacy: Clinically demonstrated to improve symptoms, reduce inflammation, and prevent disease progression.
• Multiple Indications: Versatile treatment for conditions affecting joints, gastrointestinal tract, and skin.
• Enhanced Quality of Life: Helps reduce pain, fatigue, and inflammation, enabling patients to lead more comfortable, active lives.
• Combination Therapy: Can be combined with other therapies, such as methotrexate, to maximize treatment effectiveness in rheumatoid arthritis.

Safety Information

Remicade® should be administered only by qualified healthcare professionals in a clinical setting. It is delivered via intravenous infusion over a specific duration. Patients with known hypersensitivity to infliximab or any of its components should not use this product. Common side effects may include fatigue, fever, headache, nausea, and respiratory infections. Serious adverse effects, such as infusion-related reactions, reactivation of latent infections (e.g., tuberculosis), and liver toxicity, may occur in rare cases. Patients should undergo screening for infections before initiating treatment, and regular monitoring is recommended during therapy. Pregnant or breastfeeding women should consult their healthcare provider prior to use. For full safety details, refer to the prescribing information and enclosed patient leaflet.

Pricing Information

To access specific pricing details and complete your purchase, please,  sign in to view detailed wholesale rates. Dr Sales Direct provides cost-effective solutions for medical practices, ensuring you receive high-quality products at the best prices.